External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. (Q42864027)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 October 2010

Language	Label	Description	Also known as
English	External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.	scientific article published on 7 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

prostate cancer

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Theodorus H Van der Kwast

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

9

object named as

Cora Sternberg

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Michel Bolla

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Geertjan Van Tienhoven

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jean Bernard Dubois

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

René-Olivier Mirimanoff

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Guy Storme

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jacques Bernier

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Abraham Kuten

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Ignace Billiet

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

José Lopez Torecilla

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Raphael Pfeffer

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Carmel Lino Cutajar

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Laurence Collette

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

7 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1066-1073

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of fracture after androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tables of the number of patients required in clinical trials using the logrank test.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation and radiation therapy: sequencing studies using the Shionogi in vivo tumor system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970223-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70223-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20933466%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42864027&oldid=2186353377"